Related Experiment Videos
A new modality for immunosuppression: targeting the JAK/STAT pathway
John J O'Shea1, Marko Pesu, Dominic C Borie
1Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA. osheaj@arb.niams.nih.gov
Nature Reviews. Drug Discovery
|July 3, 2004
Summary
No abstract available in PubMed .